doi: 10.3390/plants8120539 29
research support for Clinical Trials Leadership from Boehringer Ingelheim, Pfizer, AstraZeneca, Novo Nordisk, Esperion, Lilly USA, CSL Behring, and honoraria for consultancy from Lilly USA, Pfizer, Boehringer Ingelheim, Lexicon, Novo Nordisk, Applied Therapeutics, Altimmune, CSL Behring, Bayer, Intercept, New Amsterdam
Association between sarcopenic obesity, type 2 diabetes, and hypertension in overweight and obese treatmentseeking adult women
It would be a boon to have available molecules with growth factor activity which are orally active, display profound growth factor activity, and yet are inexpensive to synthesize, for the treatment of dementia and PD
Many people emphasise the emotional toll-worry, uncertainty, and the fear of continuing a medication that suddenly feels unpredictable